期刊文献+

比较雷帕霉素和吡柔比星抑制膀胱癌T24细胞生长活性的实验研究 被引量:2

Comparison of the inhibitory effect of Rapamycin and Pirarubicin on bladder cancer T24 cell
下载PDF
导出
摘要 目的对单独使用雷帕霉素(RPM)和吡柔比星(THP)抑制膀胱癌T24细胞生长活性的作用进行比较,探究雷帕霉素在膀胱肿瘤患者中的应用前景。方法建立空白对照组,将雷帕霉素和吡柔比星分别调整至10μg/mL、0.8μg/100μL,作用于膀胱癌T24细胞,处理24h后分别使用MTT法、流式细胞仪、RT-PCR和划痕法探索比较在此浓度下两种药物对膀胱癌T24细胞的影响;在体内实验,BALB/c裸鼠种植转移性人膀胱癌构建荷瘤模型。随机分为RPM(2mg/kg)、THP(0.015mg/cm2)组和空白对照组(生理盐水),观察RPM和TPH对肿瘤生长及转移的影响。结果 RPM和THP分别在10μg/mL、0.8μg/100μL质量浓度下均对膀胱癌T24细胞生长活性具有明显抑制作用,同时此浓度下RPM和THP抑制T24细胞增殖的作用无明显差异(P>0.05);RPM组下调血管生长因子(VEGF)的作用明显强于THP组(P<0.05);体内实验中,RPM和THP均显著抑制肿瘤的生长及转移。结论雷帕霉素(RPM)和吡柔比星(THP)均具有良好的抑制T24细胞生长的作用,但在此浓度下THP的细胞毒性较雷帕霉素更强,并且雷帕霉素(RPM)明显抑制膀胱癌T24细胞的生长活性的作用为治疗膀胱癌治疗提供了实验参考,表现出良好的临床应用前景。 Objective To compare the effects of Rapamycin(RPM) and Pirarubicin(THP) on inhibiting the growth and metastasis of bladder tumor T24 cell,and to investigate the therapeutic value of RPM by bladder instillation for patients with bladder tumor.Methods Human bladder tumor cell line T24 were divided into 3 groups,the control group,the RPM group and the THP group.The RPM group and the THP group were treated respectively with RPM(10ng/mL) and THP(0.8μg/100μL) for 24 h.The MTT method,Flow cytometry,RT-PCR and Scarification were applied to investigate the effect of RPM and THP on the proliferation of the T24 cells.In vivo experiment,BALB/L nude mouse planted the bladder tumor cell T24,treated by RPM(2 mg/kg) and TPH(0.05 mg/cm2) to observe the inhibtion effect on the tumor growth and metastases.Results Both RPM and THP could significantly inhibit the growth of bladder tumor cell T24,with no difference between the two groups(P0.05).However,RPM was more significant in regulating the VEGF mRNA expression than THP(P0.05).In vivo experiment showed that both RPM and THP could inhibit the growth and metastases of tumor cells.Conclusions THP and RPM can significantly inhibit the growth and metastasis of bladder tumor T24 cell,but the cytotoxicity of THP is stronger than that of RPM and RPM is more valuable for patients with bladder tumor.
出处 《现代泌尿外科杂志》 CAS 2012年第2期141-145,共5页 Journal of Modern Urology
基金 黑龙江省教育厅科学技术研究项目面上项目(No.11551192)
关键词 雷帕霉素 吡柔比星 膀胱癌 Rapamycin Pirarubicin bladder cancer
  • 相关文献

参考文献8

  • 1DONAT SM.Evaluation and follow-up strategies for superficialbladder cancer[J].Urol Clin North Am,2003,30(4):765-776.
  • 2王征,樊嘉,周俭,吴志全,邱双健,余耀,黄晓武,汤钊猷.雷帕霉素抑制肝癌细胞生长及转移的实验研究[J].中华医学杂志,2006,86(24):1666-1670. 被引量:8
  • 3刘静,夏春波,蒋常文,张晓红,门楠.吡柔比星对鼻咽癌CNE2细胞增殖和凋亡的影响[J].山东医药,2010,50(19):38-39. 被引量:2
  • 4GARRIDO-LAGUNA I,TAN AC,USON M,et al.Integratedpreclinical and clinical development of mTOR inhibitors in pancre-atic cancer[J].Br J Cancer,2010,103(5):649-655.
  • 5HANSEL DE,PLATT E,ORLOFF M,et al.Mammalian target ofrapamycin(mTOR)regulates cellular proliferation and tumorgrowth in urothelial carcinoma[J].Am J Pathol,2010,176(6):3062-3072.
  • 6PARADA B,REIS F,FIGUERIREDO A,et al.Inhibition of blad-der tumour growth by sirolimus in an experimental carcinogenesismode[lJ].BJU Int,2011,107(1):135-143.
  • 7FINGAR DC,B LENIS J.The Target of Rapamycin(TOR):Anintegra2tor of nutrient and growth fact or signals and coordinateor of cell growth and cell cycle progress is on.Oncogene,2004,23(18):3151.
  • 8周锐,陈斌,卢一平.肾移植术后肿瘤[J].现代泌尿生殖肿瘤杂志,2009,1(3):182-184. 被引量:6

二级参考文献20

共引文献13

同被引文献21

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部